The sample size was small (only 31 participants), and the researchers didnt include a placebo group
CJC-1295-related bulk drug substances (CJC-1295 [free base], CJC-1295 acetate, CJC1295 with drug affinity complex [DAC] [free base], CJC-1295 DAC acetate, and CJC-1295 DAC trifluoroacetate [TFA])
Dear Doctors: A few years ago, you mentioned a study on the idea that GLP-1 drugs might have a protective effect for people with early-stage Parkinson's disease
The FDA has cleared multiple laser devices for fat reduction and body contouring after rigorous evaluation of clinical data
The 82% average liver fat reduction and 85%+ steatosis resolution rates are unmatched
Accordingly, moderate lean tissue decline observed during GLP-1RA-induced weight loss could be interpreted as a physiological component of body composition change rather than evidence of pathological sarcopenia, unless accompanied by functional deterioration